The mechanism of action of tirzepatide and orforglipron is as follows: Orforglipron mechanism of action Orforglipron is an oral, non-peptide small-molecule medication
In the COMBINE 2 trial in individuals with T2D inadequately controlled with GLP-1RA, with or without additional oral glucose-lowering medications, IcoSema as compared to semaglutide 1.0 mg provided superiority in HbA 1c reduction from baseline to week 52 and greater improvement in fasting plasma glucose with comparable rate of combined clinically significant or severe hypoglycemia, while the weight change was in favor of semaglutide 1.0 mg [14]
This is when the scale moves most dramatically and body composition changes become visually apparent
For higher doses like 8mg, you would need to switch to a higher concentration or use a 20mg vial instead
Starting at 0.25mg for 2 weeks also gives you a clear baseline: did you feel anything
By increasing feelings of fullness, Zepbound helps manage your appetite and energy, making it easier to control your diet and reduce overeating